BioMark Diagnostics, Inc. (BUX.CX)

0.57 +0.01 (+1.79%) CAD  |  CNSX  |  Feb 24, 09:58
More

BioMark Diagnostics Average Diluted Shares Outstanding (Quarterly)

Average Diluted Shares Outstanding (Quarterly) Chart

View Average Diluted Shares Outstanding (Quarterly) for BUX.CX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Average Diluted Shares Outstanding (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Average Diluted Shares Outstanding (Quarterly) Range, Past 5 Years

View Average Diluted Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Average Diluted Shares Outstanding (Quarterly) Benchmarks

View Average Diluted Shares Outstanding (Quarterly) Benchmarks
Start Trial
Justera Health Ltd. Upgrade
Neural Therapeutics, Inc. --
ARCpoint, Inc. Upgrade
Arch Biopartners, Inc. Upgrade
Biocure Technology, Inc. Upgrade